Evidence map›Paper›PMID 41179866›Full record

ArticleFrontiers in medicine2025

Rapidly progressive relapsing polychondritis following surgery for lung adenocarcinoma: a case report.

Zhifeng Guo, Linghong Huang, Shaohua Chen, Yunfeng Chen

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhifeng Guo *Department of Respiratory Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Linghong Huang *Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Shaohua ChenDepartment of Pathology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Yunfeng ChenDepartment of Respiratory Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Relapsing polychondritis (RP) is a rare autoimmune disease. This paper reports a unique case of RP with rapid progression after surgery for lung adenocarcinoma. Case presentation: A 75-year-old man presented with a right upper lung mass on physical examination, which was finally diagnosed as invasive adenocarcinoma (stage IB) by pathology, and underwent thoracoscopic lobectomy without further chemotherapy or immunotherapy. Within 90 days after surgery, the patient developed shortness of breath, cough, and redness and swelling of the ear, and he was subsequently diagnosed with RP after pathological examination of the auricular cartilage. The patient experienced temporary improvement with mechanical ventilation, methylprednisolone, and intravenous immunoglobulin therapy, during which time comprehensive rehabilitation was initiated. However, he subsequently developed upper gastrointestinal bleeding, polymicrobial infections, and hemophagocytic syndrome, which proved fatal. Conclusion: This case highlights the rare temporal correlation of RP as a paraneoplastic syndrome that can occur prior to or concurrently with tumor onset, but it may also arise following tumor resection. Because of the rarity and adverse consequences of RP, clinicians should improve their recognition of the disease to permit early diagnosis and treatment.

Indexed as

autoimmune diseasecase reportlung adenocarcinomapostoperative progressionrelapsing polychondritis

Identifiers

PMID41179866
PMCPMC12575204

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.